tiprankstipranks
Alaunos Therapeutics (DE:WEK)
FRANKFURT:WEK

Alaunos Therapeutics (WEK) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

WEK Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Alaunos
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WEK Stock 12 Month Forecast

There Are No Analyst Ratings for DE:WEK In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

WEK Financial Forecast

WEK Earnings Forecast

Next quarter’s earnings estimate for WEK is -€0.42 with a range of -€0.42 to -€0.42. The previous quarter’s EPS was -€0.56. WEK beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year WEK has Outperformed its overall industry.
Next quarter’s earnings estimate for WEK is -€0.42 with a range of -€0.42 to -€0.42. The previous quarter’s EPS was -€0.56. WEK beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year WEK has Outperformed its overall industry.

WEK Sales Forecast

Next quarter’s sales forecast for WEK is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. WEK beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 64.18% of the time in the same period. In the last calendar year WEK has Underperformed its overall industry.
Next quarter’s sales forecast for WEK is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. WEK beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 64.18% of the time in the same period. In the last calendar year WEK has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo
€2.79
Hold
180.12%
Upside
Reiterated
08/16/23
Alaunos Therapeutics Inc. (TCRT) PT Lowered to $0.20 at Wells FargoWells Fargo analyst Yanan Zhu lowered the price target on Alaunos Therapeutics Inc. (NASDAQ: TCRT) to $0.20 (from $3.00) while maintaining a Equal Weight rating.
H.C. Wainwright
Hold
Downgraded
08/16/23
H.C. Wainwright downgrades Alaunos Therapeutics (TCRT) to a Hold
Laidlaw
Hold
Downgraded
08/15/23
Alaunos Therapeutics downgraded to Hold from Buy at LaidlawAlaunos Therapeutics downgraded to Hold from Buy at Laidlaw
Deutsche Bank
€41.81
Buy
4101.78%
Upside
Reiterated
03/08/23
Wells Fargo Keeps Their Buy Rating on Alaunos Therapeutics (TCRT)
Jefferies
€11.15
Hold
1020.47%
Upside
Reiterated
02/08/23
Alaunos Therapeutics Inc. (TCRT) PT Lowered to $0.80 at JefferiesJefferies analyst Chris Howerton lowered the price target on Alaunos Therapeutics Inc. (NASDAQ: TCRT) to $0.80 (from $1.25) while maintaining a Hold rating.

Best Analysts Covering Alaunos Therapeutics

Which Analyst Should I Follow If I Want to Buy DE:WEK and Sell After:
1 Month
James ShinDeutsche Bank
Success Rate
0/2 ratings generated profit
0%
Average Return
-17.20%
reiterated a buy rating a year ago
Copying James Shin's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -17.20% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
James ShinDeutsche Bank
Success Rate
0/2 ratings generated profit
0%
Average Return
-42.75%
reiterated a buy rating a year ago
Copying James Shin's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -42.75% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
James ShinDeutsche Bank
Success Rate
0/2 ratings generated profit
0%
Average Return
-83.50%
reiterated a buy rating a year ago
Copying James Shin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -83.50% per trade.
2 Years
James ShinDeutsche Bank
Success Rate
0/2 ratings generated profit
0%
Average Return
-82.05%
reiterated a buy rating a year ago
Copying James Shin's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -82.05% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WEK Analyst Recommendation Trends

Rating
Jan 23
Feb 23
Mar 23
May 23
Aug 23
Strong Buy
0
0
2
3
3
Buy
2
1
1
0
0
Hold
1
2
2
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
5
5
7
In the current month, WEK has received 3 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. WEK average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

WEK Stock Forecast FAQ

What is DE:WEK’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:WEK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:WEK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Alaunos Therapeutics a Buy, Sell or Hold?
      Currently, no data Available
      What is Alaunos Therapeutics’s share price target?
      Currently, no data Available
      What do analysts say about Alaunos Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Alaunos Therapeutics?
      To buy shares of DE:WEK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis